)
Wendell Yang
Founder & President,
Imgen Biosciences
Wendell Yang is the Founder and President of Imgen BioSciences Inc., with over 20 years of experience in T cell receptor (TCR)-based immunotherapy and vaccine development. He holds a PhD in Molecular Biology and Immunology from the University of Queensland, Australia. His research background includes studying the biology and mechanisms of T cell activation, particularly TCR-mediated immune synapse formation, which underpins his work in next-generation T cell therapies, including TCR-CAR-T platforms. Yang has published extensively, led NIH- and foundation-funded projects as Principal Investigator, and holds multiple international patents.